Delivery Order SPE2DB20D2014-SPE2DB24FC89W

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,169.12 and a performance period ending on September 5, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office Division, has extensive experience in supplying a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The $1,097.08 firm fixed-price delivery order contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This contract is not associated with any set-aside programs. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The $6,401.66 firm-fixed-price delivery order has a completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $15,024.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract involves the delivery of WEGOVY 0.5 mg/0.5 ml pens, which are likely a specialty pharmaceutical product. The contract has a firm fixed price and is set to be completed by September 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,151.72 firm-fixed-price delivery order is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the agency to efficiently procure a...
This federal contract award, valued at $3,125.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is a $1,286.44 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $19,267.27 firm-fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans'...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The award, valued at $3,562.38, was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 30, 2024. The contract is a delivery order with a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,462.78 firm fixed-price delivery order is for the supply of WEGOVY 1.7 mg/0.75 ml pens with a completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies and healthcare programs. The contract is not designated as a set-aside....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC89W
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The award, valued at $2,261.41, is a firm-fixed-price delivery order with an ultimate completion date of August 30, 2024. This contract is not associated with any set-aside program. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts to supply a wide range of medical products and prescription drugs to support various government agencies and healthcare programs, including the military and veterans' facilities. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for the delivery of a comprehensive range of pharmaceutical and medical supplies.

Generated 11/28/24, 9:38 AM